Lupin Limited has announced that its subsidiary, Nanomi B.V., has completed the divestiture of its entire stake in Kyowa Pharmaceutical Industry Co. Ltd to Unison Capital Partners IV, LPS, and Unison Capital Partners IV, pursuant to the satisfactory completion of all customary closing conditions.